Could regulating intestinal inflammation prevent colon cancer?

Mar 17, 2010

Every day, our gut comes in contact with bacteria, inducing an inflammatory response that is tolerated and controlled. Sometimes the control of inflammation is lost and this can lead to inflammatory bowel disease that may predispose to colon cancer. Caspase-1, an important protein involved in the mechanism of inflammation, has long been believed to be one of the culprits behind excessive inflammation in the colon. Dr. Saleh's team suggests the opposite in a new study.

The MUHC/McGill researchers have demonstrated that Caspase-1 plays a crucial role in inflammation regulation and intestinal tissue repair. But too much of any good thing can sometimes be bad. They also demonstrated that if Caspase-12--the protein that blocks Caspase-1--is absent, the inflammation mechanism caused by Caspase-1 goes out of control. Their findings, which were published in the journal Immunity, open the door to a greater understanding of and more targeted treatment strategy for preventing diseases linked to inflammation of the as well as certain cancers.

This discovery is of major interest from the therapeutic point of view because many pharmaceutical companies have developed Caspase-1 inhibitors since the late 1990s with the goal of relieving the symptoms of . However, Dr. Saleh's team observed that inhibition or deletion of Caspase-1 was not protective and actually caused an intense that led to severe colitis.

"Caspase-1 is needed to maintain the intestinal barrier and to repair it if injured. It works by stimulating the cells that line the intestinal barrier to proliferate and fill the site of damage or ulcer. This barrier shields us from the bacteria that colonize our gut," explains Dr. Saleh. "Without it, these bacteria invade to deeper tissues and trigger a persistent inflammation."

According to Dr. Saleh, the absence of Caspase-12 leads to uncontrolled cell proliferation and higher risk of colorectal cancer. "If Caspase-1 is not eventually blocked, it could lead to appearance of tumours," she says.

"Our challenge at present is to further our research on the action of Caspases in the immune response and also to see whether they play a role in other types of cancer."

Explore further: Blood and saliva tests help predict return of HPV-linked oral cancers

More information: Immunity journal: www.cell.com/immunity/newarticles

add to favorites email to friend print save as pdf

Related Stories

Protein that promotes cancer cell growth identified

Jul 24, 2009

Scientists at Burnham Institute for Medical Research (Burnham) have found that the Caspase-8 protein, long known to play a major role in promoting programmed cell death (apoptosis), helps relay signals that can cause cancer ...

Women have a more powerful immune system than men

May 12, 2009

When it comes to immunity, men may not have been dealt an equal hand. The latest study by Dr. Maya Saleh, of the Research Institute of the McGill University Health Centre and McGill University, shows that women have a more ...

Recommended for you

International charge on new radiation treatment for cancer

43 minutes ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

Computer model reveals cancer's energy source

2 hours ago

(Medical Xpress)—A computer model study reveals – for the first time – details of an energy-creating process vital and unique to cancer cells. The research holds promise for new interventions and for ...

Britain to map 100,000 DNA code sequences

5 hours ago

British scientists are to map 100,000 complete DNA code sequences in a project that will make the country a world leader in genetic research on cancer and rare diseases, the prime minister said on Friday.

User comments : 0